Clinicopathological significance of nuclear factor-kappa B, Hif-1 alpha, and vascular endothelial growth factor expression in stage III colorectal cancer

Pulmonary marginal zone B-cell lymphoma of MALT type-What is a prognostic factor and which is the optimal treatment, operation, or chemotherapy?: Consortium for Improving Survival of Lymphoma (CISL) Study

Clinical significance of preoperative serum vascular endothelial growth factor, interleukin-6, and C-reactive protein level in colorectal cancer

When do we need central nervous system prophylaxis in patients with extranodal NK/T-cell lymphoma, nasal type?

Noncutaneous malignant melanoma: A prognostic model from a retrospective multicenter study

Clinical Outcomes and Breast Cancer Subtypes in Patients with Brain Metastases

Phase II study of Gemcitabine for treatment of patients with advanced stage marginal zone B-cell lymphoma: Consortium for Improving Survival of Lymphoma (CISL) trial.

Multicentric Castleman disease complicated by tumor lysis syndrome after systemic chemotherapy.

Gastric leptomeningeal carcinomatosis: multi-center retrospective analysis of 54 cases.

Relapsed or refractory nongastric marginal zone B-cell lymphoma: Multicenter retrospective analysis of 92 cases